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Summary
 
Previous studies have suggested that granulated metrial gland (GMG) cells are bone marrow–
derived lymphoid cells, which differentiate in situ in the mouse pregnant uterus into natural
killer (NK)–like cells. Similar to NK cells, GMG cells express an abundant level of cytolytic
mediators such as perforin. The factor(s) regulating the differentiation of GMG cells remain(s)
to be identified, although cytokines previously implicated in the stimulation/activation of NK
cells (e.g., IL-2, IL-6, IL-7, and IL-12) can be considered as potential candidates. Recently,
IL-15, a novel cytokine, which displays biological activities similar to IL-2, has also been
shown to be capable of activating NK cells. Using reverse transcription–polymerase chain reac-
tion (RT-PCR) analysis, we have demonstrated in the present study that IL-15 and its cognate
receptor, but not the other cytokines, are expressed in the mouse pregnant uterus, with a time
course concomitant with those of cytolytic mediators in differentiated GMG cells. Moreover,
IL-15, though not IL-2, is capable of inducing the expression of perforin and granzymes in
pregnant uterine tissues explanted in vitro. Data obtained from in situ hybridization study have
suggested that the macrophages present in the pregnant uterus may be responsible for the pro-
duction of IL-15. These results suggest that IL-15 is involved in regulating the differentiation
of GMG cells during mouse pregnancy.
 
T
 
he metrial gland is a uterine tissue that develops adja-
cent to the placenta in pregnant rodents (1, 2). This
specialized tissue consists primarily of fibroblasts and a con-
spicuous population of granulated cells called granulated
metrial gland (GMG) cells (1, 2). Cells similar to GMG
cells, termed endometrial granulocytes, have also been found
in humans and other primates (3). Previous studies con-
ducted by us and others have indicated that GMG cells and
endometrial granulocytes belong to the NK cell lineage,
bearing both surface markers (e.g., asialo GM-1 and LGL-1)
and cytolytic mediators (e.g., perforin and granzymes) ex-
pressed by NK cells (4, 5). Although a number of hypothe-
ses regarding the biological function of perforin-expressing
GMG cells in the materno–fetal junction have been pro-
posed (6), this issue remains elusive. Moreover, although
GMG cells appear to differentiate and proliferate in situ in
the uterus during pregnancy, the factors initiating and/or
regulating their development have not been identified.
However, our previous study using pseudopregnant mice
suggested that maternal, rather than fetal, factors associated
with pregnancy are responsible for inducing the differentia-
tion of GMG cells (7). Considering that GMG cells are
NK-like cells expressing high levels of cytolytic mediators,
it is reasonable to speculate that agents capable of stimulat-
ing NK cells and/or inducing cytolytic mediators may be
involved in controlling the development of GMG cells.
Several cytokines have been shown to be able to induce
the differentiation and activation of NK cells and cytotoxic
T lymphocytes, and to induce and upregulate the expres-
sion of perforin and granzymes in these cells. These include
IL-2, IL-6, IL-7, IL-12 (8–10), and a recently identified cy-
tokine designated IL-15 (11, 12). IL-15 belongs to the
four-helix bundle cytokine family and exhibits some bio-
logical activities previously identified for IL-2 (13). More-
over, the receptor complexes for IL-15 and IL-2 share two
common subunits, the 
 
b
 
 chain and the 
 
g
 
c
 
 chain (13). In
spite of its similarities to IL-2, IL-15 is unique in its cell and
tissue distribution and probably possesses distinctive func-
tions. While IL-2 is produced predominantly by activated
T cells, IL-15 appears to be produced by a variety of cell types
and tissues, but not by T cells (13). The mRNA coding for
IL-15 has been detected in cells such as monocytes–mac-
rophages, fibroblasts, and epithelial cell lines, as well as tis-
sues and organs including spleen, skeletal muscle, and pla-
centa (13). The broad distribution of IL-15 suggests that it
may substitute for IL-2 in executing certain biological
functions in tissues where IL-2 is absent or present in low
concentrations. In view of the abundant expression of IL-15
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mRNA in placenta, it can be postulated that IL-15 may be
involved in regulating the differentiation of GMG cells
during pregnancy.
The present study is designed to investigate the possible
function of IL-15 in the mouse pregnant uterus. The results
show that the expression of IL-15 correlates closely with
the differentiation of GMG cells, and that IL-15 can en-
hance the expression of perforin in pregnant uterine tissues
maintained in short-term in vitro culture.
 
Materials and Methods
 
Animals and Tissues.
 
Pregnant C57BL/6 mice were used.
The morning a vaginal plug was found was designated as day 0.5
of gestation. On specified days of gestation, animals were killed
and the entire uterus (for gestation days 3–6; with the embryos)
or the utero–placental tissues at implantation sites (for gestation
days 8–18; without the fetus; hereafter referred to as the utero–
placental units) were aseptically removed. For extraction of RNA
or proteins, the removed tissues were immediately frozen and
stored at 
 
2
 
70
 
8
 
C until use. For tissue explant culture, the fetus-
depleted utero–placental units were minced into 2–4-mm pieces,
and cultured in 
 
a
 
-modified minimum essential medium (
 
a
 
MEM)
supplemented with 5% fetal bovine serum (FBS; Hyclone Labo-
ratory, Logan, UT) and antibiotics. In some cultures, cytokines
(IL-15 or IL-2) were added to a final concentration of 300 ng/ml.
After a 24-h incubation, the cells and tissues were harvested,
washed with PBS, and frozen for subsequent extraction of RNA
or proteins.
 
Cytokines.
 
Recombinant human IL-15 and IL-2, were pro-
vided by Immunex Co. (Seattle, WA) and Cetus Co. (Em-
eryville, CA), respectively. These two cytokines have similar mo-
lecular masses (14–15 kD) and have been shown to be capable of
functioning across species on murine cells (13).
 
Antibodies and cDNA Clone.
 
A polyclonal rabbit anti–mouse
perforin antiserum was prepared and characterized in our previ-
ous study (7). A neutralizing anti-human IL-15 antiserum and a
cDNA clone encoding murine IL-15 (13) were obtained from
Immunex.
 
Western Blot Analysis.
 
Frozen uterine tissues were thawed in
PBS containing 0.5% NP-40, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin,
1 
 
m
 
g/ml leupeptin, and 1 mM EDTA. After homogenization, the
homogenates were clarified by centrifugation and the protein
concentrations were determined using the BCA protein assay kit
(Pierce, Rockfold, IL). Aliquots of the homogenates, containing
the same amounts of protein, prepared from the tissues of differ-
ent gestational age were subjected to Western blot analysis using
an antiserum specific for mouse perforin, according to the estab-
lished protocol.
 
RT-PCR.
 
Total RNA was prepared from the uterus or the
utero–placenta unit using the RNAzol B solution (Tel-Test, Inc.,
Friendswood, TX), according to the instructions of the manufac-
turer. Complementary DNA (cDNA) was synthesized from 1 
 
m
 
g
of the isolated RNA using Moloney murine leukemia virus re-
verse transcriptase (Perkin-Elmer, Norwalk, CT). PCR using the
paired 5
 
9
 
 and 3
 
9
 
 primers for specific cytokine or cytolytic media-
tor was performed using the following protocol: 1 cycle of 3 min
at 94
 
8
 
C, 1 min at 55
 
8
 
C, and 2 min at 72
 
8
 
C; and 35 cycles of 1 min
at 94
 
8
 
C, 1 min at 55
 
8
 
C, and 1.5 min at 72
 
8
 
C. A negative control
reaction in which no RNA template was added was included in
each experiment. In each PCR reaction, a trace amount of
[
 
32
 
P]dCTP (2 
 
3
 
 10
 
5
 
 cpm/mixture) was included to label the
PCR product. The PCR products were electrophoresed on 1%
agarose gels containing ethidium bromide and visualized by UV
illumination. After photodocumentation, the agarose gels were
fixed in 10% TCA, washed, and dried under vacuum. The dried
gels were exposed to autoradiographic films or subjected to image
analysis using a PhosphorImager (Molecular Dynamics, Sunny-
vale, CA).
 
In Situ Hybridization.
 
The expression of IL-15 in the utero–
placental unit was examined by in situ hybridization using a ribo-
probe specific for murine IL-15. In brief, cryostat sections (6 
 
m
 
m)
of the utero–placental units taken from a day-9 pregnant mouse
were fixed with 4% paraformaldhyde, rinsed, dehydrated, dena-
tured, and hybridized with either the dioxigenin-labeled antisense
or sense IL-15 riboprobe at 42
 
8
 
C overnight. After washing, slides
were incubated with an alkaline phosphatase–conjugated anti-
dioxigenin antibody for 1 h at room temperature. After washing,
the slides were incubated with a substrate solution containing
5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazo-
lium salt to visualize the cells that hybridized with the riboprobe.
The preparation of dioxigenin-labeled antisense and sense ribo-
probes from the murine IL-15 cDNA and the visualization of the
hybridized cells were performed using the Genius Dig RNA-
labeling kit (Boehringer Mannheim, Indianapolis, IN).
 
Results and Discussion
 
Time Course of the Expression of the mRNAs Encoding Cy-
tokines and Cytolytic Mediators in the Pregnant Uterus.
 
GMG
cells are bone marrow–derived NK-like cells that differen-
tiate in situ within the pregnant uterus and reside predomi-
nantly in the metrial gland and decidua basalis (14, 15). In
mouse, the differentiation of these cells begins at the time
when implantation of the embryo takes place (day 4.5 of
gestation), peaks around days 12–14 of gestation, and sub-
sides thereafter (15). The differentiation of GMG cells is
accompanied by the increased expression of cytolytic medi-
ators, e.g., perforin, in these cells (15, 16). The factor(s) or
mechanism(s) controlling this pregnancy-associated biolog-
ical process remain(s) elusive. During pregnancy, the uter-
ine endometrium undergoes remarkable cellular changes
referred to as decidualization (17). Cell populations in the
decidualized uterine tissue are heterogeneous, including
gland epithelial cells, fibroblasts, macrophages, lymphoid cells,
and other stromal cells (17). Many of these cells are capable
of secreting cytokines which in term may influence the de-
velopment or functional activities of other cell populations
in a paracrine manner (18–22). Because the appearance of
GMG cells in the pregnant uterus coincides with decidual-
ization of the uterine tissue (15), it is conceivable that cyto-
kines or other humoral factors (e.g., gestational hormones
[23]) present locally in the decidual tissue are involved in
initiating or regulating the differentiation of GMG cells. In
view of the close relationship between GMG cells and NK
cells in terms of their morphological, phenotypical, and
biochemical features, these two cell types may be subjected
to similar biological stimuli. We therefore sought to exam-
ine whether cytokines previously implicated in the activa-
tion of NK cells, including IL-2, IL-6, IL-7, IL-12, and IL-15,
are expressed in the mouse pregnant uterus and, if so, 
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whether these cytokines are involved in regulating GMG
cell differentiation.
The expression of mRNAs encoding IL-2, IL-6, IL-7,
IL-12, and IL-15 in the pregnant uterus was investigated by
RT-PCR analysis, using RNA extracted from the entire
uterus (before pregnancy or on gestation day 3, 4, and 6) or
the utero–placental units (gestation day 8 onward). The
products of RT-PCR were examined by visualization on
electrophoresed gels (Fig. 1). The results obtained demon-
strated that, while the mRNAs coding for IL-2 and IL-7
were essentially undetectable throughout the gestational
period investigated, the mRNAs for IL-6 and IL-12 ap-
peared to be constantly present in the pregnant uterus (data
for IL-12 not shown). Although the message levels for IL-6
and IL-12 fluctuated to some extent during gestation, no
distinct peaks for their expression were observed. In con-
trast, the expression of IL-15 seemed to be restricted to the
late–early to mid gestational period, ranging from gestation
day 6 to day 11 (Fig. 1). The two essential components of
the IL-15 receptor complex, the 
 
a
 
 chain (IL-15R
 
a
 
) and
the 
 
b
 
 chain (IL-15/IL-2R
 
b
 
), were also expressed in the
pregnant uterus, with the former expressed concomitantly
with IL-15. In contrast, the 
 
a
 
 chain of the IL-2 receptor
complex (IL-2R
 
a
 
), which is required for the high affinity
binding of IL-2, was absent in the pregnant uterus (Fig. 1).
These latter findings further suggested that IL-15, but not
IL-2, may be responsible for executing immunoregulatory
function(s) in the pregnant uterus.
The expression of mRNAs encoding cytolytic media-
tors in the pregnant uterus was similarly examined using
RT–PCR analysis. Interestingly, the expression of mRNAs
coding for perforin, granzyme A (GA), granzyme B (GB),
and Fas ligand (FasL) appeared to commence on day 6 and
reached the maximum on day 9 of gestation (Fig. 1). The
time frames of cytolytic mediator mRNA expression in the
pregnant uterus correlate well with those of IL-15 and
IL-15R
 
a
 
, suggesting a role for IL-15 as an inducer of the ex-
pression of these cytolytic mediators in this unique local
environment. Since IL-6 and IL-12, two other cytokines
capable of inducing cytolytic mediator expression (9, 10),
are also present in the pregnant uterus (Fig. 1; data shown
only for IL-6), it is possible that they may act in conjunc-
tion with IL-15 to achieve a full-scale immunoregulation.
 
Effects of IL-15 on the Expression of Perforin in the Utero–
Placental Explants.
 
The above-described concomitant ex-
pression of IL-15 and different cytolytic mediators by
GMG cells provides supporting yet circumstantial evidence
that IL-15 may be responsible for the differentiation of
these cells during pregnancy. To obtain additional evidence
attesting to this hypothesis, we sought to investigate di-
rectly the biological effects of IL-15 on GMG cells. Previ-
ous studies, however, have demonstrated that GMG cells
are very fragile and can be easily damaged during various
mechanical or enzymatic manipulations essential for their
isolation from the pregnant uterus (24). To circumvent this
technical problem which may thwart the availability of in-
tact GMG cells for further studies in vitro, we opted to uti-
lize explant culture prepared from pregnant uteri. Based on
the previous studies indicating that GMG cells represent
the dominant, if not the exclusive, cell population produc-
ing cytolytic mediators in the pregnant uterus (15, 16), the
results obtained using the pregnant uterus explants can be
considered as being representative of those obtained using
cultured GMG cells.
Minced pieces (2–4 mm) of the uterus (prior to gestation
day 6) or the utero–placental unit (gestation day 8 and af-
terwards) were maintained at 37
 
8
 
C in medium with or
without the indicated cytokine. IL-15 or IL-2 was used at
300 ng/ml, a concentration previously demonstrated to be
effective in stimulating cytotoxic lymphocytes including
NK cells (12). After a 24-h culture, the tissues and cells mi-
grating out from the explants were harvested and their
RNAs and proteins were extracted. To monitor the differ-
entiation of GMG cells, the induction/enhancement of
perforin expression in the cultured explants was examined.
Using RT–PCR coupled with a semiquantitative Phos-
phorimager analysis, it was determined that the explants
cultured in the presence of IL-15 (300 ng/ml) expressed
two- to tenfold more perforin mRNA than those cultured
in the absence of cytokine (Fig. 2). In contrast, IL-2 (300
ng/ml) exerted no detectable effect on the explants simi-
larly prepared. This in vitro induction effect by IL-15 was
observed only in the explants prepared from pregnant mice
at gestation ages between day 8 and day 12. No significant
induction or increase of perforin expression could be de-
tected in the explants of pregnant uterus removed before
gestation day 6 or after gestation day 13 (data not shown).
These results suggested that cells present in the explants,
probably GMG cells, are susceptible to the stimulation by
Figure 1. Expression of mRNAs encoding lymphocyte cytolytic medi-
ators, cytokines, and cytokine receptors in the pregnant uterus, investi-
gated by RT-PCR analysis (see Materials and Methods). 
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IL-15 within a limited time period during pregnancy. This
is consistent with the above-described finding that mRNA
coding for IL-15R
 
a
 
, which is imperative for cellular re-
sponses specific to IL-15, was expressed in the pregnant
uterus in vivo between gestation day 8 through day 12 (see
Fig. 1). The IL-15-induced expression of perforin could
also be detected by Western blot analysis of the proteins
extracted from the explants (Fig. 3). Moreover, the induc-
tion of perforin by IL-15 was completely abolished by the
addition of a neutralizing anti-IL-15 antibody (Figs. 2 and 3;
data shown only for the day 12 explant). Induction of GA
and GB by IL-15, but not IL-2, in the explants removed
from mice between gestation day 8 and day 12 was also
observed. However, the extent of the induction of these
two mediators was always smaller (approximately twofold;
data not shown) than those of perforin. Interestingly, in
these experiments, it was found that the biological effects of
IL-15 were more evident at the earlier stage during the
gestation period (10-fold increase of perforin mRNA in
day 8 explants versus twofold increase in day 12 explants).
These differential effects were probably due to the less ad-
vanced differentiation and the lower endogenous perforin
level of day 8 GMG cells, which rendered these cells more
responsive to IL-15 than the highly differentiated day 12
GMG cells.
These in vitro studies, together with the investigation on
the correlative expression of mRNAs encoding IL-15,
IL-15R
 
a
 
, and cytolytic mediators in vivo (see Fig. 1), suggest
rather strongly the role of IL-15 as the principal inducer/
regulator of differentiation of GMG cells in the pregnant
uterus. Although it has been reported that IL-2, at high
concentrations, could stimulate the cytolytic activity of
GMG cells in vitro (25), our study indicates that IL-2 is
Figure 2. Effects of IL-15 and IL-2 on the expression of perforin
mRNA in pregnant uterus. The explants of pregnant uterus prepared on
the indicated days of gestation were cultured for 24 h in medium alone,
or in medium supplemented with either IL-15 or IL-2. The RNAs pre-
pared from the cultured explants were subjected to RT-PCR and Phos-
phorImager analysis. The level of the expression of perforin mRNA in
the explants obtained on the indicated day of gestation was determined
based on the ratio of the PCR product specific for perforin to that for
b-actin. The perforin/b-actin ratios obtained in the RNAs prepared from
the explants cultured in the presence of cytokines were then normalized
against those obtained from the explants cultured in medium alone.
Figure 3. Effects of IL-15 and IL-2 and the production of perforin pro-
tein in pregnant uterus. Proteins extracted from the cultured explants of
pregnant uterus were subjected to Western blot analysis using an anti-per-
forin antiserum. Lanes 1, with medium; lane 2, with IL-15; lane 3, with
IL-2; lane 4, with IL-15 and anti-IL-15.
Figure 4. Expression of IL-15 in the preg-
nant uterus analyzed by in situ hybridization.
Sections of an implantation site in a pregnant
uterus of day 9 of gestation were hybridized
with dioxygenin-labeled antisense (A and C) or
sense (B and D) riboprobe specific for murine
IL-15. Some cells residing in the decidua basalis
(DB) (arrows) appeared to hybridize specifically
with the antisense probe, indicating the expres-
sion of IL-15 mRNA in these cells.  
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probably not involved in regulating the differentiation of
GMG cells in vivo.
 
Localization of IL-15-producing Cells in the Pregnant Uterus.
 
Another question pertinent to the biological function of
IL-15 during pregnancy is the following: which cell popu-
lation present in the pregnant uterus is responsible for the
production of this cytokine? Since both macrophages and
fibroblasts, two cell types known to produce IL-15, have
been shown to be present in large numbers in the pregnant
uterine tissue, they may be responsible for producing IL-15
in the local environment. Other cells, such as uterine epi-
thelial cells and trophoblasts, as well as GMG cells them-
selves, have also been reported to be capable of secreting
cytokines (18–20). The possibility that these cells may also
contribute to the production of IL-15 in the pregnant
uterus therefore can not be excluded. To address this issue,
we examined the sections of the utero–placental units by in
situ hybridization using riboprobes specific for IL-15. The
results showed that some cells residing in the decidua basalis
could hybridize to the antisense probe for IL-15 (Fig. 4).
According to their anatomical localization, these IL-15-
expressing cells appeared to be macrophages, but not GMG
cells. Moreover, cells expressing IL-15 messages were not
detected in the labrynthine placenta, excluding the possi-
bility that trophoblasts may be an important source of
IL-15 (data not shown). Studies aimed at elucidating more
precisely the identity of the IL-15-expressing cells (e.g.,
immunohistocytochemical staining using antibodies spe-
cific for macrophage surface markers) are underway.
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